What is the global market size of Home Dialysis Systems Market?

Global Home Dialysis Systems Market size was valued at around USD 17.5 billion in 2021 and is expected to reach a value of USD 42.29 billion by 2030, at a CAGR of 10.3% over the forecast period (2022–2030).

Who are the key vendors in the Global Home Dialysis Systems Market?

The global home dialysis systems market is fragmented and highly competitive. Key industry players are focused on product developments, new product launches, and geographical expansions to gain a significant amount of market share. 'Fresenius Medical Care AG & Co. KGaA Baxter International, Inc. (the US)', 'Nikkiso Co., Ltd. (Japan)', 'B. Braun Melsungen AG (Germany)', 'Asahi Kasei Corporation (Japan)', 'DaVita Inc. (US)', 'Nipro Corporation (Japan)', 'Cantel Medical Corporation (US)', 'Diaverum (Germany)', 'Medtronic plc. (Ireland)', 'Rockwell Medical, Inc. (the US)', 'Becton, Dickinson, and Company (US)', 'Dialife SA (Switzerland)', 'Isopure Corp. (US)'

Home Dialysis Systems Market Size

Home Dialysis Systems Market Insights

Global Home Dialysis Systems Market size was valued at USD 22.34 billion in 2023 and is poised to grow from USD 24.69 billion in 2024 to USD 54.87 billion by 2032, growing at a CAGR of 10.5% during the forecast period (2025-2032).

Technological developments, transplant risks, increased incidence of chronic renal illnesses, initiatives by key companies to introduce new products and services, and a shortage of organ donors are a few factors boosting demand for home dialysis systems, hence fueling market expansion. For example, transferring Outset Medical, Inc., a medical technology company trying to reduce the complexity and cost of dialysis, joined Health Home, an alliance of innovative healthcare firms intending to drastically rethink the way policymakers think about home healthcare, in May 2021. They hope to urge politicians to reconsider the home as a center of care for clinical treatment, such as chronic disease management, through collaborations in the healthcare sector. As a result of these activities, the market is expected to grow in the near future.

During the COVID-19 pandemic, patients with kidney failure who usually have immunological dysfunction have profited immensely from the remote patient management platform, allowing them to complete their dialysis at home, where they may be safer by socially isolating themselves. Baxter International Inc., for example, unveiled the premium Analytics share source 1.0 module, the next generation of digital health for home-based peritoneal dialysis patients, in June 2021. Share source Analytics 1.0 is a clinical management resource available as part of the Share source remote patient management platform that offers healthcare providers a full dashboard containing trend data from their patients' home dialysis treatments. Baxter plans to collect a monthly fee and spread out the product globally over the next year, beginning in the United States.

The rising frequency of chronic renal disease is predicted to drive up demand for home dialysis equipment. ESKD, also known as end-stage renal disease, affects approximately 786,000 people in the United States, according to the Centers for Disease Control and Prevention (CDC) 2020 estimate, with 29% requiring a kidney transplant and 71% requiring dialysis. According to the same source, 12.5% of all dialysis patients did their dialysis at home by the end of 2018. The number of patients receiving home dialysis more than doubled between 2008 and 2018. As a result, market growth is expected to accelerate in the near future. In 2021, the United States dominated the market. The demand for home care dialysis services is predicted to rise throughout the forecast period as a result of various initiatives conducted by organizations and governments. As part of a kidney care campaign, America's Health Insurance Plans (AHIP) will support access to home dialysis in 2019. Additionally, Baxter International Inc. fully supported the administration's Advancing American Kidney Health Initiative in July 2019. The Administration hopes that by 2031, the number of new end-stage renal disease (ESRD) patients obtaining organ transplants and home dialysis would have climbed to 80%.

US Home Dialysis Systems Market is poised to grow at a sustainable CAGR for the next forecast year.

FAQs

The global home dialysis systems market is fragmented and highly competitive. Key industry players are focused on product developments, new product launches, and geographical expansions to gain a significant amount of market share. 'Fresenius Medical Care AG & Co. KGaA (Germany) ', 'Baxter International Inc. (United States) ', 'B. Braun Melsungen AG (Germany) ', 'Medtronic plc (Ireland) ', 'Nipro Corporation (Japan) ', 'Asahi Kasei Medical Co., Ltd. (Japan) ', 'Diaverum (Sweden) ', 'Kimal plc (United Kingdom) ', 'Becton, Dickinson and Company (BD) (United States) ', 'Quanta Dialysis Technologies (United Kingdom) ', 'Outset Medical, Inc. (United States) ', 'Rockwell Medical, Inc. (United States) ', 'Dialife SA (Switzerland) ', 'Medivators Inc. (United States) ', 'Nikkiso Co., Ltd. (Japan) ', 'NantHealth, Inc. (United States) '

The market is expanding due to technical advancements, transplant risks, growth in the frequency of chronic renal disorders, efforts by large players to develop improved products and services, and a lack of organ donors. Outset Medical, Inc., a medical technology business whose aim is to minimize the complexity and cost of dialysis, has joined Health Home, an alliance of innovative healthcare companies whose mission is to radically change policymakers' perceptions of home diagnostics. They hope to persuade authorities to reconsider the home as a clinical treatment facility for chronic disease management through collaboration in the healthcare sector. These initiatives are projected to drive market growth during the forecast period.

The use of peritoneal dialysis, whose products are portable and offer convenience, particularly at patients' homes, is a key trend in the global market for home dialysis systems. It is popular among the elderly because it does not require the patient to be awake. As a result, several market players are developing peritoneal dialysis products, and some are also conducting research and development (R&D) to advance the technology.

North America dominated the home dialysis systems market in 2021, with a revenue share of more than 38.40%. Significant government investments in the creation of novel medical devices, the existence of important participants, and the presence of a good reimbursement system are all contributing to the region's market growth. Home dialysis is becoming more popular as the prevalence of chronic kidney disease (CKD) rises. Other factors influencing market growth include rising healthcare spending, increasing disposable income, and government efforts. For example, Innovate Kidney Care, a new initiative supported by nine leading healthcare organizations, will launch in June 2021 to increase patient options for receiving home dialysis support and training. Among the initial members are CVS Kidney Care, Anthem, Inc., the American Society of Nephrology (ASN), Cricket Health, Intermountain Healthcare, Outset Medical, Inc., the National Kidney Foundation (NKF), and Strive Health. Innovate Kidney Care's purpose is to achieve four goals: better patient outcomes, better healthcare practitioner experience, better patient experience, and lower healthcare expenditures.